1. Basyte-Bacevice, Viktorija, Skieceviciene, Jurgita, Valantiene, Irena, Lammert, Frank, Kupcinskas, Juozas. 2019. TM6SF2 and MBOAT7 Gene Variants in Liver Fibrosis and Cirrhosis. In International journal of molecular sciences, 20, . doi:10.3390/ijms20061277. https://pubmed.ncbi.nlm.nih.gov/30875804/
2. Li, Ting-Ting, Li, Tao-Hua, Peng, Juan, Zheng, Xi-Long, Tang, Zhi-Han. 2017. TM6SF2: A novel target for plasma lipid regulation. In Atherosclerosis, 268, 170-176. doi:10.1016/j.atherosclerosis.2017.11.033. https://pubmed.ncbi.nlm.nih.gov/29232562/
3. Deng, Guo-Xiong, Yin, Rui-Xing, Guan, Yao-Zong, Wu, Jin-Zhen, Miao, Liu. 2020. Association of the NCAN-TM6SF2-CILP2-PBX4-SUGP1-MAU2 SNPs and gene-gene and gene-environment interactions with serum lipid levels. In Aging, 12, 11893-11913. doi:10.18632/aging.103361. https://pubmed.ncbi.nlm.nih.gov/32568739/
4. Tang, Shan, Zhang, Jing, Mei, Ting-Ting, Qiu, Li-Xia, Yu, Hai-Bin. 2019. Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis. In BMC cancer, 19, 1128. doi:10.1186/s12885-019-6173-4. https://pubmed.ncbi.nlm.nih.gov/31752753/
5. Zhu, Wenzhen, Liang, Wenying, Lu, Haocheng, Chen, Y Eugene, Guo, Yanhong. 2022. Myeloid TM6SF2 Deficiency Inhibits Atherosclerosis. In Cells, 11, . doi:10.3390/cells11182877. https://pubmed.ncbi.nlm.nih.gov/36139452/
6. Trépo, Eric, Valenti, Luca. 2020. Update on NAFLD genetics: From new variants to the clinic. In Journal of hepatology, 72, 1196-1209. doi:10.1016/j.jhep.2020.02.020. https://pubmed.ncbi.nlm.nih.gov/32145256/
7. Chouik, Yasmina, Di Filippo, Mathilde, Radenne, Sylvie, Moulin, Philippe, Levrero, Massimo. 2024. Combination of heterozygous APOB gene mutation with PNPLA3 and TM6SF2 variants promotes steatotic liver disease, cirrhosis and HCC development. In Liver international : official journal of the International Association for the Study of the Liver, 44, 1474-1477. doi:10.1111/liv.15837. https://pubmed.ncbi.nlm.nih.gov/38421084/
8. Luo, Fei, Smagris, Eriks, Martin, Sarah A, Hobbs, Helen H, Cohen, Jonathan C. 2021. Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats. In Cellular and molecular gastroenterology and hepatology, 13, 879-899. doi:10.1016/j.jcmgh.2021.12.008. https://pubmed.ncbi.nlm.nih.gov/34923175/
9. Anstee, Quentin M, Darlay, Rebecca, Cockell, Simon, Cordell, Heather J, Daly, Ann K. 2020. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆. In Journal of hepatology, 73, 505-515. doi:10.1016/j.jhep.2020.04.003. https://pubmed.ncbi.nlm.nih.gov/32298765/
10. Chen, Yanhua, Du, Xiaomeng, Kuppa, Annapurna, Palmer, Nicholette D, Speliotes, Elizabeth K. 2023. Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease. In Nature genetics, 55, 1640-1650. doi:10.1038/s41588-023-01497-6. https://pubmed.ncbi.nlm.nih.gov/37709864/
智鼠故事 
